Large-scale testing (Phase 3)Study completedNCT01086969What this trial is testingMeningococcal Vaccine, Menactra® in Healthy Subjects in IndiaWho this might be right forMeningococcal InfectionMeningitis Sanofi 300
Large-scale testing (Phase 3)Active Not RecruitingNCT07135986What this trial is testingImmunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Children and Adolescents in ChinaWho this might be right forMeningococcal InfectionHealthy Volunteers Sanofi 1,602
Large-scale testing (Phase 3)Study completedNCT03964012What this trial is testingStudy to Assess Immunegnicity & Safety of Pentavalent Meningococcal Vaccine (NmCV-5)Who this might be right forMeningococcal Meningitis Serum Institute of India Pvt. Ltd. 1,800
Large-scale testing (Phase 3)Study completedNCT01410474What this trial is testingImmunogenicity and Safety of Meningococcal ACWY Conjugate Vaccine in Healthy Subjects From 2 to 18 Years in TaiwanWho this might be right forBacterial Meningitis Novartis 341
Early research (Phase 1)UnknownNCT02878291What this trial is testingSafety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 MonthsWho this might be right forMeningitis, Meningococcal Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 200
Early research (Phase 1)Study completedNCT00678652What this trial is testingPhase 1 Safety and Immunogenicity of Meningococcal VaccineWho this might be right forMeningococcal Infection, Group B U.S. Army Medical Research and Development Command 36
Large-scale testing (Phase 3)Study completedNCT01274897What this trial is testingA Multi-center, Observer-blind, Placebo-controlled, Randomized Study to Evaluate the Immunogenicity and Safety of MenACWY in Adolescents and Adults in KoreaWho this might be right forMeningococcal DiseaseMeningococcal Meningitis Novartis Vaccines 450
Large-scale testing (Phase 3)Study completedNCT01154088What this trial is testingImmunogenicity and Safety of Meningococcal Vaccine GSK 134612 Versus Mencevax™ ACWY in Healthy 18-25 Year OldsWho this might be right forInfections, Meningococcal GlaxoSmithKline 1,170
Testing effectiveness (Phase 2)Study completedNCT00427908What this trial is testingStudy in Children to Evaluate Non-Inferiority and Persistence up to 5 Years of GSK Bio Meningococcal Vaccine 134612Who this might be right forInfections, Meningococcal GlaxoSmithKline 613
Testing effectiveness (Phase 2)Study completedNCT00454909What this trial is testingImmunogenicity and Safety of Meningococcal Vaccine GSK134612 vs. Menactra® in Healthy Adolescent/Adults Aged 10-25 Years.Who this might be right forInfections, Meningococcal GlaxoSmithKline 873
Testing effectiveness (Phase 2)Study completedNCT02640404What this trial is testingSafety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in VietnamWho this might be right forMeningitisMeningococcal MeningitisMeningococcal Infections Sanofi Pasteur, a Sanofi Company 224
Large-scale testing (Phase 3)Study completedNCT04142242What this trial is testingStudy to Assess the Safety and Immunogenicity of a Single Dose of a Quadrivalent Meningococcal (MenACYW) Conjugate Vaccine in Older Adults Who Received a Primary Vaccination (3 or More Years Earlier) in Study MET49Who this might be right forMeningococcal Infection (Healthy Volunteers) Sanofi Pasteur, a Sanofi Company 471
Testing effectiveness (Phase 2)Study completedNCT00661557What this trial is testingComparison of GSK134612 in Subjects Previously Vaccinated Against Meningococcal Disease Versus Non-vaccinated SubjectsWho this might be right forInfections, Meningococcal GlaxoSmithKline 271
Large-scale testing (Phase 3)Study completedNCT03537508What this trial is testingImmunogenicity and Safety of a Quadrivalent Meningococcal Conjugate Vaccine When Administered Concomitantly With Routine Pediatric Vaccines in Healthy Infants and Toddlers in the USWho this might be right forHealthy Volunteers (Meningococcal Infection) Sanofi Pasteur, a Sanofi Company 2,627
Testing effectiveness (Phase 2)Study completedNCT05229536What this trial is testingImmunogenicity and Safety of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Volunteers Aged From 3 to 35 MonthsWho this might be right forMeningitis, Meningococcal Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 720
Post-approval studies (Phase 4)Study completedNCT01659996What this trial is testingStudy of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of AgeWho this might be right forMeningitisMeningococcal InfectionDiphtheria+3 more Sanofi Pasteur, a Sanofi Company 1,394
Not applicableStudy completedNCT04665791What this trial is testingA Human Controlled Infection Study with Neisseria Lactamica in Malian AdultsWho this might be right forMeningitis, Meningococcal Center for Vaccine Development - Mali 55
Large-scale testing (Phase 3)Study completedNCT01777308What this trial is testingImmunogenicity, Reactogenicity and Safety of GlaxoSmithKline (GSK) Biologicals' MenACWY-TT Vaccine Administered 6 Years Post-MenC Primary Vaccination in Healthy Subjects Who Were 12-18 Months at Primary VaccinationWho this might be right forInfections, Meningococcal GlaxoSmithKline 156
Large-scale testing (Phase 3)Study completedNCT01352793What this trial is testingA Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 YearsWho this might be right forMeningitis, Meningococcal Pfizer 5,715
Large-scale testing (Phase 3)Study completedNCT01235975What this trial is testingImmunogenicity and Safety Study of GSK Biologicals' Meningococcal Vaccine Given as One Dose to Healthy Subjects Above 56 YearsWho this might be right forInfections, Meningococcal GlaxoSmithKline 400